Pricing Log in Create free account

Cantor Equity Partners, Inc. (CEPO) vs Drugs Made In America Acquisition Corp. (DMAA)

Cantor Equity Partners, Inc. and Drugs Made In America Acquisition Corp. are both Shell Companies companies. Cantor Equity Partners, Inc. and Drugs Made In America Acquisition Corp. are of similar size ($274.4M and $263.8M).

Valuation

Metric CEPO DMAA Shell Companies median
P/E n/m — 38.02
P/S n/m — 12.19
P/B n/m — 1.91
Price to free cash flow n/m — 28.89
EV/EBITDA — — —
EV/Sales — — —
Earnings yield (2.69%) — 1.77%
Free cash flow yield 0.00% — (0.81%)

Profitability

Metric CEPO DMAA Shell Companies median
Gross margin — — 71.01%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity 68.61% — 0.88%
Return on assets (3.49%) — 1.98%
Return on invested capital 0.00% — 0.00%

Growth

Metric CEPO DMAA Shell Companies median
Revenue growth (TTM) — — —
EPS growth (last fiscal year) (1,497.63%) — 0.00%
Revenue growth, 5-year CAGR — — —
Net income growth, 5-year CAGR — — 0.00%

Health

Metric CEPO DMAA Shell Companies median
Debt to equity 0.00 — 0.00
Current ratio 0.11 — 0.10
Net debt to EBITDA 0.03 — 0.06

Dividend

Metric CEPO DMAA Shell Companies median
Dividend yield — — —
Payout ratio — — —

Size

Metric CEPO DMAA Shell Companies median
Market cap 274.38m 263.77m 152.75m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack